BioTech
-
Taysha, Gilead, Merck, Zentalis news
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Read More » -
Marea, a biotech company seeking to tackle heart disease, raises $190 million
A 10-person startup called Marea said Tuesday that it had raised $190 million to help develop a drug to lower…
Read More » -
Takeda, Disc Medicine, Covid-19 vaccines
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Read More » -
J.P. Morgan, mifepristone, Cabaletta Bio news
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Read More » -
FDA seeks public input on advisory committees
The day an FDA advisory committee met to weigh the merits of an experimental treatment for amyotrophic lateral sclerosis was…
Read More » -
Duchenne gene therapy setback, Alzheimer’s drug endorsement
On this week’s episode of “The Readout LOUD,” our STAT colleague Nicholas Florko joins us to explain what it means…
Read More » -
Biopharma execs cheer Supreme Court for backing FDA in abortion case
On Thursday, the Supreme Court rejected an effort by anti-abortion doctors to bar the mailing of the abortion pill mifepristone.…
Read More » -
Readout Newsletter: Pfizer, Avidity, Geron updates
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Read More » -
Will Geron be acquired? The long-short view
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it…
Read More » -
Pfizer’s gene therapy for Duchenne muscular dystrophy fails trial
Pfizer said Wednesday afternoon that a closely watched gene therapy for Duchenne muscular dystrophy failed to slow the disease’s progression…
Read More »